(108 days)
Not Found
No
The summary describes a surgical suture and a manual delivery device, with no mention of AI or ML capabilities in the device description, intended use, or performance studies.
No
The device is a surgical suture and delivery system used for tissue approximation and ligation, which are procedures to repair or hold tissues together, rather than treat a disease or condition.
No
The device is a surgical suture and delivery system used for tissue approximation and ligation, not for diagnosing medical conditions.
No
The device description explicitly states it is a surgical suture and a delivery device, both of which are physical hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "general soft tissue approximation and/or ligation" and is used in surgical procedures. This describes a device used in vivo (within the body) for surgical purposes.
- Device Description: The description details a surgical suture and a delivery device used to place the suture within the body. This aligns with a surgical device, not a diagnostic one.
- Lack of Diagnostic Elements: There is no mention of analyzing samples (blood, tissue, etc.), detecting biomarkers, or providing diagnostic information. IVD devices are designed to perform tests on samples taken from the body to diagnose or monitor conditions.
Therefore, the GazelleTM PTFE suture and Delivery Device is a surgical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Gazelle PTFE (polytetrafluroethylene) suture and Delivery Device is indicated for use in general soft tissue approximation and/or ligation, including; cardiovascular, dental, general surgical procedures and repair of the dura mater. GazelleTM PTFE sutures are not indicated for use in microsurgery, ophthalmic procedures, or peripheral neural tissues. GazelleTM PTFE suture and Delivery Device is provided sterile as a single use device.
Product codes
NBY
Device Description
The Gazelle PTFE surgical sutures are monofilament surgical sutures composed from expanded polytetrafluoroethylene (ePTFE) material. They are uncoated, undyed monofilament sutures composed from expanded polytetrafluoroethylene (ePTFE) material. The sutures are attached to a standard stainless steel surgical needle.
The Gazelle Delivery Device is a Class I Manual Surgical Instrument that assists with suture placement. The PTFE suture is loaded into the Gazelle Delivery Device and is delivered to the desired location through the Gazelle device tip by pressing the actuation button on the Gazelle device handle.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
general soft tissue, cardiovascular, dental, dura mater
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Data: Gazelle PTFE Surgical Sutures meet the requirements specified in FDA's Class II Special Controls Guidance Document: Surgical Sutures, Guidance for Industry and FDA". In addition, the PTFE suture has passed performance testing, including mechanical testing in accordance to USP for nonabsorbable suture and biocompatibility testing of the suture material in accordance with ISO 10993-1. Packaging and sterilization validation and shelf life testing have been successfully performed. The Gazelle Delivery Device was tested for Button Push Force, Distal Tip / Shaft Pull Force, Handle / Shaft Pull Force, Stylet / Button Pull Force and underwent surgeon evaluation. All testing has confirmed that the Gazelle PTFE Suture and Delivery System is substantially equivalent to it's predicate and will meet customer / user performance requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.5035 Nonabsorbable expanded polytetrafluoroethylene surgical suture.
(a)
Identification. Nonabsorbable expanded polytetrafluoroethylene (ePTFE) surgical suture is a monofilament, nonabsorbable, sterile, flexible thread prepared from ePTFE and is intended for use in soft tissue approximation and ligation, including cardiovascular surgery. It may be undyed or dyed with an approved color additive and may be provided with or without an attached needle(s).(b)
Classification. Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the FDA logo is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
February 8, 2018
Dura Tap, LLC % Ms. Vikki O'Connor Ambriel Associates, Inc. Regulatory Affairs Consultant 411 Walnut St., Unit 9236 Green Cove Springs, Florida 32043
Re: K173335
Trade/Device Name: Gazelle PTFE Suture and Delivery Device Regulation Number: 21 CFR 878.5035 Regulation Name: Nonabsorbable expanded polytetrafluoroethylene surgical suture Regulatory Class: Class II Product Code: NBY Dated: November 17, 2017 Received: November 21, 2017
Dear Ms. O'Connor:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
David Krause -S
for Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
510(k) Number (if known) K173335
Device Name
Gazelle PTFE Suture and Delivery Device
Indications for Use (Describe)
GazelleTM PTFE (polytetrafluroethylene) suture and Delivery Device is indicated for use in general soft tissue approximation and/or ligation, including; cardiovascular, dental, general surgical procedures and repair of the dura mater. Gazelle™PTFE sutures are not indicated for use in microsurgery, ophthalmic procedures, or peripheral neural tissues. GazelleTM PTFE suture and Delivery Device is provided sterile as a single use device.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (7/17)
Page 1 of 1
PSC Publushing Services (301) 443-6740 EF
3
510(k) Summary: Gazelle PTFE (polytetrafluroethylene) Suture and Delivery Device
In accordance with Title 21 of the Code of Federal Regulations, Part 807, and in particular, 21 CFR Part 807.92, the following summary of information is provided:
| Submitter: | Dura Tap LLC
Wayne, PA
USA |
|----------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person | Ms. Vikki M. O'Connor
Regulatory Affairs Consultant
Phone: 1-207-214-8535
Email: vikki0730@yahoo.com |
| Date Prepared | January 12, 2017 |
| Trade Name | Gazelle PTFE Suture and Delivery Device |
| Proposed Class | Class II (special controls); General and Plastic Surgery |
| Classification Name
and Number | Suture, Surgical, Nonabsorbable, Expanded,
Polytetraflouroethylene, 878.5035 |
| Common Name | PTFE Nonabsorbable Surgical Sutures |
| Product Code | NBY |
| Predicate Device | Riverpoint Medical MONOTEX PTFE Suture – K140415 |
| Special Controls | FDA Guidance, “Class II Special Controls Guidance
Document: Surgical Sutures, Guidance for Industry and
FDA" was followed during the preparation of this
submission. |
| Device Description | The Gazelle PTFE surgical sutures are monofilament
surgical sutures composed from expanded
polytetrafluoroethylene (ePTFE) material. They are |
| | The sutures are attached to a standard stainless steel
surgical needle. |
| | The Gazelle Delivery Device is a Class I Manual
Surgical Instrument that assists with suture placement. |
| | The PTFE suture is loaded into the Gazelle Delivery
Device and is delivered to the desired location through
the Gazelle device tip by pressing the actuation button
on the Gazelle device handle. |
| Intended Use | The Gazelle PTFE (polytetrafluroethylene) Suture and
Delivery Device are indicated for use in general soft tissue
approximation and / or ligation, including cardiovascular,
dental, general surgical procedures and repair of the dura
mater. Gazelle PTFE Sutures are not indicated for use in
microsurgery, ophthalmic procedures, or peripheral neural
tissues. Gazelle PTFE Sutures are provided sterile as a
single use device. |
| Summary of the
Technological
Characteristics | Gazelle PTFE Surgical Sutures are uncoated, undyed
monofilament sutures composed from expanded
polytetrafluoroethylene (ePTFE) material. The sutures are
provided sterile for single use and meet all applicable USP
requirements. |
| Performance Data | Gazelle PTFE Surgical Sutures meet the requirements
specified in FDA's Class II Special Controls Guidance
Document: Surgical Sutures, Guidance for Industry and
FDA". In addition, the PTFE suture has passed
performance testing, including mechanical testing in
accordance to USP for nonabsorbable suture and
biocompatibility testing of the suture material in
accordance with ISO 10993-1. Packaging and
sterilization validation and shelf life testing have been
successfully performed. The Gazelle Delivery Device
was tested for Button Push Force, Distal Tip / Shaft Pull |
| | Force, Handle / Shaft Pull Force, Stylet / Button Pull Force
and underwent surgeon evaluation. All testing has confirmed
that the Gazelle PTFE Suture and Delivery System is
substantially equivalent to it's predicate and will meet
customer / user performance requirements. |
| Summary of
Similarities and
Differences | Both the subject and predicate are monofilament PTFE
(polytetrafluroethylene) Nonabsorbable Surgical Sutures.
Both are available in USP size 5-0 and 6-0 and are
attached to stainless steel surgical needles. Both are
uncoated and undyed. Both are provided sterilized for
single use. Both meet USP requirements for Nonabsorbale
Surgical Sutures, Tensile Strength and Needle Attachment.
Riverpoint Surgical MONOTEX PTFE Sutures may not
meet the USP requirement for diameter where Gazelle
PTFE Sutures do meet the USP requirement for diameter.
The only other difference is that the Gazelle PTFE suture is
pre-loaded into the Gazelle Delivery Device. |
| Conclusion | Based on the indications for use, technological
characteristics, required performance testing and
comparison to the predicate device, Gazelle PTFE Suture
and Delivery Device has been shown to be substantially
equivalent to legally marketed predicate devices for its
intended use. |
4
5